Stugeron Janssen treats cerebral circulatory disorders (25 blisters x 10 tablets)

Dosage form Tablet
Specifications Box of 25 blisters x 10 tablets
Ingredient Cinnarizine

Ingredient

Thành phần cho 1 viên

Composition information	Content
Cinnarizine	25mg

Uses

Indications

Stugeron 25mg drug is indicated in the following cases:

Brain circulation disorders

Treatment maintains symptoms of cerebrovascular origin, including dizziness, tinnitus, blood vessel headache, stimulating and close -up disorders, memory loss and lack of concentration.

Migraine migraine prevention.

balance disorders

Treatment maintains symptoms of methane disorders, including dizziness, dizziness, tinnitus, eyeball, nausea and vomiting.

Foreign circulation disorders

Treatment maintains the symptoms of peripheral circulatory disorders, including the raynaud phenomenon, head purple, limb, limp, nutritional disorders, nutrient ulcers and varicose veins, abnormalities, cramps at night, cold head.

Treers

Prevention of motion sickness.

Pharmacokic

cinnarizin inhibits the contraction of blood vessel muscle cells by blocking calcium channels. In addition to direct calcium channel blockers, cinnarizin is also a decrease in the vascular activity of vascular substances such as norepinephrin and serotonin, by blocking calcium channels operating by receptors. The blockade of calcium cell entrance has a selective tissue properties, and provides vascular resistance properties without impact on blood pressure and heart rate.

In addition, cinnarizin can improve microcirculation decline by increasing the ability to change the shape of red blood cells and reduce blood viscosity. The drug increases cell resistance for tissue reduction.

cinnarizin inhibits the stimulation of the vestibular system, helping to reduce eyeball and other plant disorders. Acute dizziness can be prevented or removed by cinnarizin.

pharmacokinetic

absorption

Cinnarizin's peak plasma concentration is achieved within 1-3 hours after drinking.

Distribution

The ability to bind to the plasma protein of cinnarizin is 91%.

Metabolism

cinnarizin is metabolized mainly through CYP2D6.

Elimination

The half -life of cinnarizin is recorded from 4 to 24 hours. The elimination of these metabolites occurs about 1/3 through the urine and 2/3 through the feces.

Before taking Stugeron Janssen treats cerebral circulatory disorders (25 blisters x 10 tablets)

How to use

Take oral, should be taken after meals.

Dosage

Cerebral circulatory disorders

Adults: 1 tablet 25 mg, 3 times/day.

Adults: 2 - 3 capsules 25 mg, 3 times/day.

Adults and teenagers aged 13 years and older: 1 tablet of 25 mg at least half an hour before departure, repeat every 6 hours. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

Symptoms and signs

Overdose when using cinnarizin has been reported at a dose of 90 to 2250 mg. jerk.

There is no specific antidote. Symptomatic treatment and supportive treatment are mainly for any overdose. Activated carbon can be used if it is appropriate. However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Stugeron 25mg, you may experience unwanted effects (ADR).

Common, ADR> 1/100

Nervous system: Sleep.

Digestive system: Nausea.

Systemic: gain weight.

Uncommon, 1/1000

Nervous system: Sleep, sleeping.

Digestive system: discomfort in the stomach, vomiting, upper abdominal pain, indigestion.

Skin and subcutaneous tissue: Increase sweating.

Body: tired.

Very rare, ADR

Nervous system: movement disorders, pagoda disorders, Parkinson's syndrome, Run.

Skin and subcutaneous tissue: Lichen horn, flat lichen, lupus in the skin of the skin.

Muscle system, connective tissue and bone: Muscle spasticity.

Instructions on how to handle ADR:

Notify the doctor with unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Stugeron drug 25mg contraindicated for patients with hypersensitivity to the drug.

Be cautious when using

as well as other antihistamines, Stugeron 25mg can cause pain in the epigastric area, taking medicine after meals that can reduce stomach irritation.

In Parkinson patients, Stugeron should only use 25mg when the benefits of using drugs are superior to the risk that can worsen this disease.

Stugeron 25 mg can be drowsy, especially at the beginning of treatment. Therefore, be careful when used with alcohol, central nervous system inhibitors or three -round antidepressants.

The ability to drive and operate machinery

Because sleepiness may occur, especially at the beginning of treatment, so be cautious in activities such as driving, operating machinery.

Pregnancy

Despite the animal studies, Stugeron 25mg has proved not to have a teratogenic effect. Like other drugs, Stugeron 25mg should only be used during pregnancy when the benefits are higher than the potential risk to the fetus.

Breastfeeding period

There is no data on the excretion of Stugeron 25mg through breast milk, so it is not recommended for breastfeeding in women who are using Stugeron 25mg.

Medicinal interaction

alcohol, central nervous system inhibitors, and 3 -round antidepressants

The sedative effect of Stugeron 25mg and of any of the following factors can increase when used simultaneously: alcohol, central neurological inhibitors or three -round antidepressants.

Diagnostic intervention

Due to the antihistamine effect, Stougeron 25mg can prevent positive reactions with skin reaction indicators if used within 4 days before testing skin reaction.

Storage

Store at a temperature of 15 - 30oC.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.